Disease activity impacts disability progression in primary progressive multiple sclerosis

被引:16
|
作者
Marrodan, M. [1 ]
Bensi, C. [1 ]
Pappolla, A. [2 ]
Rojas, J. I. [2 ,3 ]
Gaitan, M. I. [1 ]
Ysrraelit, M. C. [1 ]
Negrotto, L. [1 ]
Fiol, M. P. [1 ]
Patrucco, L. [2 ,3 ]
Cristiano, E. [3 ]
Farez, M. F. [1 ,4 ]
Correale, J. [1 ]
机构
[1] Fleni, Dept Neurol, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[3] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
[4] Fleni, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Primary progressive multiple sclerosis; PPMS; Multiple Sclerosis; Disability worsening; Disability progression; NATURAL-HISTORY; PROGNOSTIC-FACTORS; MRI; MS; PREDICTORS;
D O I
10.1016/j.msard.2019.101892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective: To describe the clinical characteristics, presence or absence of MRI activity, and natural history of a PPMS cohort from two referral centers in Argentina and assess whether clinical and/or radiological disease activity correlated with disability worsening. Methods: Retrospective study conducted at two MS clinics in Buenos Aires, Argentina, through comparative analysis of patients with and without evidence of disease activity. Results: Clinical and/or radiologic activity was presented in 56 (31%) of 178 patients. When stratified by age at onset, we found that for every 10 years of increase in age at onset, risk of reaching EDSS scores of 4 and 6 increased by 26% and 31%, respectively (EDSS 4: HR 1.26, CI 95%: 1.06-1.50; EDSS 6: HR 1.31, CI 95%: 1.06-1.62). Patients who presented clinical exacerbations reached EDSS scores of 6, 7 and 8 faster than those without associated exacerbations (p = 0.009, p = 0.016 and p = 0.001, respectively). Likewise, patients who presented gadolinium-enhancing lesions during the course of disease reached EDSS scores of 7 earlier (p = 0.002). Conclusion: Older age at onset and presence of clinical and/or radiological disease activity correlated with accelerated disability progression in this cohort of PPMS patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Disease onset in familial and sporadic primary progressive multiple sclerosis
    Koch, M.
    Zhao, Y.
    Yee, I.
    Guimond, C.
    Kingwell, E.
    Rieckmann, P.
    Sadovnick, D.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 694 - 700
  • [22] Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis
    Souissi, A.
    Mrabet, S.
    Nasri, A.
    Ben Djebara, M.
    Gargouri, A.
    Kacem, I.
    Gouider, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [23] Impact of Age on Multiple Sclerosis Disease Activity and Progression
    Zeydan, Burcu
    Kantarci, Orhun H.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2020, 20 (07)
  • [24] Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability
    Flachenecker, P
    Reiners, K
    Krauser, M
    Wolf, A
    Toyka, KV
    MULTIPLE SCLEROSIS, 2001, 7 (05): : 327 - 334
  • [25] Cortical lesion load associates with progression of disability in multiple sclerosis
    Calabrese, Massimiliano
    Poretto, Valentina
    Favaretto, Alice
    Alessio, Sara
    Bernardi, Valentina
    Romualdi, Chiara
    Rinaldi, Francesca
    Perini, Paola
    Gallo, Paolo
    BRAIN, 2012, 135 : 2952 - 2961
  • [26] Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
    Ana Paula Kallaur
    Sayonara Rangel Oliveira
    Andréa Name Colado Simão
    Daniela Frizon Alfieri
    Tamires Flauzino
    Josiane Lopes
    Wildea Lice de Carvalho Jennings Pereira
    Caio de Meleck Proença
    Sueli Donizete Borelli
    Damacio Ramón Kaimen-Maciel
    Michael Maes
    Edna Maria Vissoci Reiche
    Molecular Neurobiology, 2017, 54 : 2950 - 2960
  • [27] Treatment of Primary Progressive Multiple Sclerosis
    Kantarci, Orhun
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 74 - 77
  • [28] Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
    Bsteh, Gabriel
    Marti, Stefanie
    Krajnc, Nik
    Traxler, Gerhard
    Salmen, Anke
    Hammer, Helly
    Leutmezer, Fritz
    Rommer, Paulus
    Di Pauli, Franziska
    Chan, Andrew
    Berger, Thomas
    Hegen, Harald
    Hoepner, Robert
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 93
  • [29] Primary Progressive Multiple Sclerosis-A Key to Understanding and Managing Disease Progression
    Sempik, Izabela
    Dziadkowiak, Edyta
    Moreira, Helena
    Zimny, Anna
    Pokryszko-Dragan, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [30] Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
    Tallantyre, E. C.
    Bo, L.
    Al-Rawashdeh, O.
    Owens, T.
    Polman, C. H.
    Lowe, J.
    Evangelou, N.
    BRAIN, 2009, 132 : 1190 - 1199